Get the latest insights, educational opportunities, and activities to inform your treatment approach for dogs with arthritis.

Resources to share with dog owners


Get materials to share with your clients to help them learn about early indicators of canine osteoarthritis (OA) and support your treatment recommendation to help keep their dog moving comfortably.

Client Questionnaire:

What's your dog's OA risk?


Clients can review this questionnaire to get an idea of whether their dog is at risk for developing arthritis or may be already experiencing painful symptoms. Download the questionnaire and share with them, then be prepared to discuss the results.

DOWNLOAD NOW

Digital Brochure:

Adequan Canine Pet Parent Brochure


Share this brochure with clients to help educate them on why treating their dog’s arthritis can help them enjoy more active years together.

DOWNLOAD NOW
ENGLISH
DOWNLOAD NOW
SPANISH

Dosing Schedule:

Stay on Track with Recommended Dosing


Helping clients follow the recommended dosing schedule for Adequan Canine helps deliver optimal results.

DOWNLOAD NOW

Dosing Card:

Confirm Accurate Dosage and Administration by Body Weight


Use this quick reference dosing card to ensure OA treated dogs are receiving the recommended Adequan Canine dose per injection.

DOWNLOAD NOW

Infographic:

5 Top Breeds and Their Risk for Canine Osteoarthritis (OA)


Share this with clients to help them understand how arthritis affects dogs of different breeds and sizes.

DOWNLOAD NOW

Infographic:

Playful Pup or Couch Potato?


Use this to educate clients about what arthritis looks like in its early stages.

DOWNLOAD NOW

Resources for you and your team


Use these tools and resources to enhance your team’s knowledge of canine arthritis and strengthen your ability to diagnose and treat it early.

TECHNICAL BULLETIN:

A Disease-Modifying Osteoarthritis Drug


Learn how Adequan Canine treats the disease, not just the symptoms. See its unique characteristics and the distinct advantages of using it to treat arthritis early.



DOWNLOAD NOW

TREATMENT RESOURCE:

Adequan Canine Product Comparison Handout


This digital flyer is a good way to teach your team and dog owners about the primary features and benefits of Adequan Canine.



DOWNLOAD NOW

TREATMENT RESOURCE:

FDA-Approved Adequan Canine vs. Other Treatments


Understand the importance of FDA approval and different options available like Adequan Canine, NSAIDs, supplements and medical devices.

DOWNLOAD NOW

RACE-approved online CE courses


Take advantage of our free, fully accredited continuing education courses to keep your license up to date. Select the appropriate button below to be taken directly to the site where you can review and complete the CE course, undergo testing validation, and receive your certificate of completion.

CASE-BY-CASE:

Profiling Adequan Canine (polysulfated glycosaminoglycan)


This course lets you see how 3 veterinarians examined, evaluated, and helped manage 4 different dogs with OA. It provides a better understanding of what to watch for, the benefits of treating canine OA, and patient owner challenges. (0.5 CE)

VETERINARIANS NURSES/TECHNICIANS

OA CHALLENGES:

It’s More Than Just Pain


Learn about the stages of canine osteoarthritis with Dr. Julia Tomlinson as she takes you through real cases to help you know how to identify and manage canine OA early in the disease process. (1.0 CE)

VETERINARIANS NURSES/TECHNICIANS

SOCIALLY DISTANCED VETERINARIANS DRINKING COFFEE:

Canine OA Edition


Join Dr. Whit Cothern and his team of experts—Dr. Denis Marcellin-Little, Dr. David Dycus, and Dr. Julia Tomlinson—as they discuss early detection, exam techniques, and treatment options for canine OA. (1.0 CE)

VETERINARIANS NURSES/TECHNICIANS

OSTEOARTHRITIS:

What Should You Do and When?


Learn how you can use your position as a licensed professional to do more to recognize and help manage OA in dogs. (0.5 CE)

VETERINARIANS NURSES/TECHNICIANS

Adequan® Canine polysulfated glycosaminoglycan (PSGAG)

INDICATIONS AND USAGE
Adequan® Canine is recommended for intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.

IMPORTANT SAFETY INFORMATION
Adequan® Canine should not be used in dogs who are hypersensitive to PSGAG or who have a known or suspected bleeding disorder. It should be used with caution in dogs with renal or hepatic impairment. Adverse reactions in clinical studies (transient pain at injection site, transient diarrhea, and abnormal bleeding) were mild and self-limiting. In post approval experience, death has been reported in some cases; vomiting, anorexia, depression/lethargy and diarrhea have also been reported. The safe use of PSGAG in breeding, pregnant or lactating dogs has not been evaluated. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For additional safety information, please see full prescribing information.

Stock up on Adequan Canine


Contact a distributor to stock your shelves with Adequan® Canine (polysulfated glycosaminoglycan) so you’re ready to start recommending it for your canine patients with arthritis.

REACH OUT

Let’s keep in touch

Stay in the know about the latest Adequan® Canine news, information, resources and more.

GET UPDATES